The drugmaker, which has signed semi-exclusive licensing partnerships with Lupin and Torrent Pharma, has regulatory approval to make and market semaglutide for both type 2 diabetes and weight management
Patients with Fabry disease experience peripheral neuropathy, sensory abnormalities, acute pain crises, and lifelong ongoing pain [82]

Aqua(Water), Glycerin, Butylene Glycol, Methylpropanediol, Oryza Sativa (Rice) Bran Water, Boron Nitride, Niacinamide, 1,2-Hexanediol, Hydroxyacetophenone, Carbomer, Arginine, Ethylhexyl Palmitate, Propanediol, Glycereth-25 PCA Isostearate, Sodium Polyacrylate, Cetyl Ethylhexanoate, Maltodextrin, Panthenol, Ethylhexylglycerin, Xanthan Gum, Polyglyceryl-10 Oleate, Coptis Japonica Root Extract, Adenosine, Trisodium Ethylenediamine Disuccinate, Ascorbic Acid, Hydrogenated Lecithin, Oryza Sativa (Rice) Extract, Theobroma Cacao (Cocoa) Seed Extract, Dextrin, Lactobacillus/Rice Ferment, Hyaluronic Acid, Hydrolyzed Hyaluronic Acid, Sodium Hyaluronate, Sodium Phytate, Sodium Lauroyl Lactylate, Sodium DNA, Acetyl Hexapeptide-8, Ceramide NP, Copper Tripeptide-1, Ceramide AP, Phytosphingosine, Cholesterol, Oligopeptide-29, Oligopeptide-32, Palmitoyl Pentapeptide-4, Ceramide EOP
48: 8819 Sima AAF, Bouchier M, Christensen H